바이오라 테라퓨틱스(BIORQ)는 NASDAQ에 상장된 기업입니다. 현재가 $0.22 (+0.00%), 시가총액 $5.
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc.
바이오라 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
바이오라 테라퓨틱스의 현재 주가는 $0.22 (+0.00%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
바이오라 테라퓨틱스의 시가총액은 약 $5입니다.
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.